133 related articles for article (PubMed ID: 7477890)
1. [D-Pen2,D-Pen5]enkephalin, a delta opioid agonist reduces endogenous aluminum content in the rat central nervous system.
Gulya K; Szikra J; Kása P
Neuroscience; 1995 May; 66(2):499-506. PubMed ID: 7477890
[TBL] [Abstract][Full Text] [Related]
2. Partial depletion of endogenous zinc level by (D-Pen2, D-Pen5)enkephalin in the rat brain.
Gulya K; Kovács GL; Kása P
Life Sci; 1991; 48(12):PL57-62. PubMed ID: 1848338
[TBL] [Abstract][Full Text] [Related]
3. Effects of NMDA receptor antagonists on delta1- and delta2-opioid receptor agonists-induced changes in the mouse brain [3H]DPDPE binding.
Cao YJ; Bian JT; Bhargava HN
Eur J Pharmacol; 1997 Sep; 335(2-3):161-6. PubMed ID: 9369369
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of brain N-methyl-D-aspartate receptors following multiple intracerebroventricular injections of [D-Pen2, D-Pen5] enkephalin and [D-Ala2, Glu4]deltorphin II in mice.
Bhargava HN; Kumar S; Bian JT
Peptides; 1997; 18(10):1609-13. PubMed ID: 9437723
[TBL] [Abstract][Full Text] [Related]
5. Regulation of endogenous calcium and magnesium levels by delta opioid receptors in the rat brain.
Gulya K; Kovács GL; Kása P
Brain Res; 1991 Apr; 547(1):22-7. PubMed ID: 1650284
[TBL] [Abstract][Full Text] [Related]
6. Chronic effect of [D-Pen2,D-Pen5]enkephalin on rat brain opioid receptors.
Tao PL; Tsai CL; Chang LR; Loh HH
Eur J Pharmacol; 1991 Aug; 201(2-3):209-14. PubMed ID: 1665782
[TBL] [Abstract][Full Text] [Related]
7. Evidence for delta opioid receptor subtypes in rat spinal cord: studies with intrathecal naltriben, cyclic[D-Pen2, D-Pen5] enkephalin and [D-Ala2, Glu4]deltorphin.
Stewart PE; Hammond DL
J Pharmacol Exp Ther; 1993 Aug; 266(2):820-8. PubMed ID: 8394918
[TBL] [Abstract][Full Text] [Related]
8. Characterization of [3H][2-D-penicillamine, 5-D-penicillamine]-enkephalin binding to delta opiate receptors in the rat brain and neuroblastoma--glioma hybrid cell line (NG 108-15).
Akiyama K; Gee KW; Mosberg HI; Hruby VJ; Yamamura HI
Proc Natl Acad Sci U S A; 1985 Apr; 82(8):2543-7. PubMed ID: 2986120
[TBL] [Abstract][Full Text] [Related]
9. Effects of chronic administration of 7-benzylidene-7-dehydronaltrexone and naltriben on the antinociceptive actions of delta 1- and delta 2-opioid receptor agonists.
Bhargava HN; Zhao GM; House RV; Thomas PT
Eur J Pharmacol; 1996 Sep; 311(2-3):127-32. PubMed ID: 8891592
[TBL] [Abstract][Full Text] [Related]
10. Effect of chronic administration of [D-Pen2, D-Pen5] enkephalin on the activity of nitric oxide synthase in brain regions and spinal cord of mice.
Bhargava HN; Cao YJ
Peptides; 1998; 19(1):113-7. PubMed ID: 9437743
[TBL] [Abstract][Full Text] [Related]
11. Differential modulation by [D-Pen2, D-Pen5]enkephalin and dynorphin A-(1-17) of the inhibitory bladder motility effects of selected mu agonists in vivo.
Sheldon RJ; Nunan L; Porreca F
J Pharmacol Exp Ther; 1989 May; 249(2):462-9. PubMed ID: 2566676
[TBL] [Abstract][Full Text] [Related]
12. Role of steric interactions in the delta opioid receptor selectivity of [D-Pen2, D-Pen5]enkephalin.
Mosberg HI; Haaseth RC; Ramalingam K; Mansour A; Akil H; Woodard RW
Int J Pept Protein Res; 1988 Jul; 32(1):1-8. PubMed ID: 2851561
[TBL] [Abstract][Full Text] [Related]
13. DAMGO ([D-Ala2,NMePhe4,Gly-ol]enkephalin), but not DPLPE ([D-Pen2,L- Pen5]enkephalin), specifically inhibits methamphetamine-induced behavioral responses in the mouse.
Ukai M; Toyoshi T; Kameyama T
Neuropharmacology; 1993 Oct; 32(10):1019-24. PubMed ID: 8295712
[TBL] [Abstract][Full Text] [Related]
14. [D-Pen2, D-Pen5]enkephalin, the standard delta opioid agonist, induces morphine-like behaviors in mice.
Murray CW; Cowan A
Psychopharmacology (Berl); 1990; 102(3):425-6. PubMed ID: 2251341
[TBL] [Abstract][Full Text] [Related]
15. Heroin acts on different opioid receptors than morphine in Swiss Webster and ICR mice to produce antinociception.
Rady JJ; Roerig SC; Fujimoto JM
J Pharmacol Exp Ther; 1991 Feb; 256(2):448-57. PubMed ID: 1847196
[TBL] [Abstract][Full Text] [Related]
16. Effects of [D-Ala2, D-Leu5]enkephalin and [D-Pen2, L-Pen5]enkephalin on apomorphine-induced motor activity in the mouse.
Ukai M; Toyoshi T; Kameyama T
Pharmacol Biochem Behav; 1992 Jan; 41(1):171-6. PubMed ID: 1311454
[TBL] [Abstract][Full Text] [Related]
17. Evidence for mu opioid receptor mediation of enkephalin-induced electroencephalographic seizures.
Tortella FC; Robles L; Mosberg HI
J Pharmacol Exp Ther; 1987 Feb; 240(2):571-7. PubMed ID: 3027318
[TBL] [Abstract][Full Text] [Related]
18. Effects of multiple intracerebroventricular injections of [D-Pen2,D-Pen5]enkephalin and [D-Ala2,Glu4]deltorphin II on tolerance to their analgesic action and on brain delta-opioid receptors.
Zhao GM; Bhargava HN
Brain Res; 1997 Jan; 745(1-2):243-7. PubMed ID: 9037415
[TBL] [Abstract][Full Text] [Related]
19. [D-Pen2-D-Pen5]enkephalin, a delta opioid agonist, given intracerebroventricularly in the mouse produces antinociception through medication of spinal GABA receptors.
Holmes BB; Fujimoto JM
Pharmacol Biochem Behav; 1994 Nov; 49(3):675-82. PubMed ID: 7862723
[TBL] [Abstract][Full Text] [Related]
20. Discriminative stimulus effects of a centrally administered, delta-opioid peptide (D-Pen2-D-Pen5-enkephalin) in pigeons.
Jewett DC; Mosberg HI; Woods JH
Psychopharmacology (Berl); 1996 Oct; 127(3):225-30. PubMed ID: 8912400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]